Work

The antimalarial ferroquine: from bench to clinic

Year: 2011
Type: review
Abstract: Ferroquine (FQ, SSR97193) is currently the most advanced organo-metallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocene-containing compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falciparum and P. vivax strains and/or isolates. This article focuses on the discovery of FQ, its antimalarial activity, the hypothesis of its mode of action, the current absence of resistance in vitro and recent clinical trials.
Source: Parasite
Language: Spanish
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $1,695
OpenAlex ID: W2021547498
FWCI: 1.853
Cites: 45
Cited by: 189
Related to: 10